StockData
FCHSOTCServices-Medical LaboratoriesFiscal year ends December 31

First Choice Healthcare Solutions, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.01−0.00 (-3.61%)

Close on Oct 19, 2026

Market cap
$263.67K
P/E (TTM)
–
Dividend yield
–

First Choice Healthcare Solutions, Inc. revenue by segment

By business segment

Operating incomeTTM Q3 18TTM Q2 18TTM Q1 18TTM Q4 17TTM Q3 17TTM Q2 17TTM Q1 17TTM Q4 16TTM Q3 16TTM Q2 16TTM Q1 16TTM Q4 15YoY
FCID Medical [Member]$395.36K$413.51K$559.30K$726.73K$1.13M$1.66M$2.42M$1.84M$2.61M$1.44M$273.67K$340.99K-65.1%
Brevard Orthopaedic [Member]-$211.38K-$55.73K-$531.44K-$951.22K$973.86K$1.03M$1.39M$1.18M$1.22M$2.80M$2.30M$1.95M-121.7%
Corporate [Member]-$3.66M-$3.55M-$3.62M-$3.34M-$3.22M-$3.10M-$3.56M-$3.01M-$5.78M-$5.75M-$4.80M-$4.58M+13.6%
Marina Towers [Member]––––––––––$759.49K$711.19K–
Intersegment Elimination [Member]–––––––––––$0–
The Crane Center [Member]–––-$844.81K-$925.60K-$397.88K$4.24K$128.74K–––––

By product or service

By region

From the segment and revenue-disaggregation notes of First Choice Healthcare Solutions's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.